Antenatal features and management of alobar holoprosencephaly: a case study
European Gynecology & Obstetrics · 22.05.2025 · 7 (1)
DOI: 10.53260/ego.257014 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Gynecology & Obstetrics, online erschienen am 22.05.2025. Verfasst von Jelloul Rayhane und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Holoprosencephaly (HPE) is a congenital malformation of the brain and face due to incomplete cleavage of the prosencephalon. It affects one in 15,000 to 16,000 births. A 37-year-old patient with a medical history of type 2 diabetes under insulin treatment, and an infection with SARS-CoV-2 at 17 weeks of gestation during this pregnancy was referred to us at 21 weeks gestation following the discovery at the second-trimester ultrasound of an alobar HPE. A multidisciplinary meeting concluded that a termination of pregnancy was necessary given the poor neurological prognosis. Although, HPE is a rare congenital brain malformation. Prenatal ultrasound is the preferred diagnostic tool for detecting the condition and determining the need for pregnancy termination
Zitieren
APA
Rayhane, J., Salim, Z., Khaoula, S., & Aida, M. (2025). Antenatal features and management of alobar holoprosencephaly: a case study. European Gynecology & Obstetrics, 7(1). https://doi.org/10.53260/ego.257014
Vancouver
Rayhane J, Salim Z, Khaoula S, Aida M. Antenatal features and management of alobar holoprosencephaly: a case study. European Gynecology & Obstetrics. 2025;7(1). doi:10.53260/ego.257014
BibTeX
@article{Rayhane2025,
author = {Rayhane, Jelloul and Salim, Zangar and Khaoula, Samaali and Aida, Masmoudi},
title = {Antenatal features and management of alobar holoprosencephaly: a case study},
journal = {European Gynecology & Obstetrics},
year = {2025},
volume = {7},
number = {1},
doi = {10.53260/ego.257014}
}
EUVIMED